CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma

(marketscreener.com) REHOVOT, Israel and BETHESDA, MD, Nov. 8, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. , a global leader in the development of cancer related medicine, announced today that it has acquired a controlling interest in TaGeza Biopharmaceuticals Ltd. The TaGeza research team remains committed to the company, and co-founder Prof....https://www.marketscreener.com/quote/stock/CNBX-PHARMACEUTICALS-INC-120793400/news/CNBX-to-Enter-the-Cancer-Immunotherapy-Market-After-Acquiring-a-Controlling-Interest-in-TaGeza-Bioph-42242187/?utm_medium=RSS&utm_content=20221108